Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Credit card points can unlock a variety of rewards, from travel to cashback. Discover the possibilities and make the most of your points.
28,188 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
As AI expands, the backbone—data centers and compute—becomes a focal point for investors. This guide compares CoreWea...
Investors chase stocks with accelerating growth and clear catalysts. This guide explains how to identify a supercharg...
Quantum tech is moving from dream to data. This article explores Rigetti Computing, its revenue path, risks, and a pr...
As Berkshire Hathaway prepares for a new era, Warren Buffett successor Greg Abel may be quietly orchestrating a bold,...
SpaceX has dazzled investors, but big bets come with big risks. This article explains three reasons reasons spacex st...
Two heavyweight banks reported solid Q4 2025 results, but investors remain focused on dividends, buybacks and how eac...
Florida enters its worst drought in a generation, worsening the squeeze on citrus farmers already dealing with diseas...
As inflation reaccelerates, a potential rate hike under a new Fed chair could complicate Trump’s midterm plans and ri...
A JPMorgan-led projection suggests about $165 billion in stock sales could hit markets as major funds rebalance portf...
AI-driven investment has become a major growth engine for the U.S. economy, but a slowdown could ripple across jobs, ...
The U.S. economy posted 2.2% growth for 2025, a modest slowdown from 2024, with late-year softness in Q4. Consumers a...